Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?-Reference-Cited by-同舟云学术

Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?

Published:2022-10-18 Issue:12 Volume:24 Page:1741-1750
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Wang Yifan,Strazzabosco Mario,Madoff David C.^ORCID

Funder

National Institute of Health

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11912-022-01338-5.pdf

Reference85 articles.

1. Yoo C, Shin SH, Park JO, Kim KP, Jeong JH, Ryoo BY, et al. Current status and future perspectives of perioperative therapy for resectable biliary tract cancer: a multidisciplinary review. Cancers. 2021;13(7):1647.

2. Patel N, Benipal B. Incidence of cholangiocarcinoma in the USA from 2001 to 2015: a US cancer statistics analysis of 50 states. Cureus. 11(1):e3962

3. Cancer of the Liver and Intrahepatic Bile Duct - Cancer Stat Facts. SEER. Available from: https://seer.cancer.gov/statfacts/html/livibd.html. Accessed 27 July 2022.

4. Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729245.

5. Turati F, Bertuccio P, Negri E, Vecchia CL. Epidemiology of cholangiocarcinoma. Hepatoma. Research. 2022;12(8):19.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis;Frontiers in Microbiology;2023-11-14

2. Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma;Frontiers in Microbiology;2023-01-06